Pharma News Intelligence January 5, 2024
Veronica Salib

Eli Lilly and Company is launching LillyDirect, a digital healthcare platform used to manage obesity, migraine, and diabetes for patients in the US.

Yesterday, January 4, 2024, Eli Lilly and Company issued a press release announcing the launch of LillyDirect. The platform is a digital healthcare tool for managing and supporting patients with obesity, migraine, and diabetes in the United States.

According to the release, LillyDirect offers multiple services for disease management, support, and medication delivery.

The press release highlights multiple features but primarily focuses on the LillyDirect Pharmacy Solutions feature. Through LillyDirect Pharmacy Solutions, the company’s platform connects users to a third-party online pharmacy fulfillment service. The thought behind this aspect is to make it easier for patients to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Digital Health, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Technology, Telehealth
Related Articles:
JP Morgan Annual Healthcare Conference 2025: What are the key talking points likely to be?
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
Key Trends in the Evolution of PBMs and Their Future Impact on Drug Pricing and Pharmacy Operations

Share This Article